首页|期刊导航|中国临床药理学杂志|右酮洛芬氨丁三醇与氟比洛芬酯在妇科日间手术术后镇痛的临床研究

右酮洛芬氨丁三醇与氟比洛芬酯在妇科日间手术术后镇痛的临床研究OA

Clinical trial of dexketoprofen trometamol and flurbiprofen axetil in postoperative analgesia for gynecological day surgery

中文摘要英文摘要

目的 比较右酮洛芬氨丁三醇注射液与氟比洛芬酯注射液用于妇科短小日间手术术后镇痛的非劣效性.方法 采用单中心、前瞻性、随机、双盲、阳性药物平行对照、非劣效性试验.将择期行妇科短小日间手术[(美国麻醉医师协会(ASA)Ⅰ~Ⅱ级]的患者随机分为对照组和试验组.试验组于手术结束前10 min静脉注射右酮洛芬氨丁三醇注射液50 mg,对照组静脉注射氟比洛芬酯注射液50 mg.比较2组出麻醉后监护室(PACU)时的数字评定量表(NRS)疼痛评分(非劣效界值设为1.0分)、入PACU和出PACU时的Ramsay镇静量表(RSS)评分、里士满躁动-镇静量表(RASS)评分、布氏舒适度量表(BCS)评分、补救镇痛率,以及术后24 h 15项恢复质量量表(QoR-15)和理查兹-坎贝尔睡眠问卷(RCSQ)评分并进行安全性评价.结果 共入组86例,对照组和试验组各43例.出PACU时,对照组和试验组NRS评分分别为1.00(1.00,2.00)和2.00(0,2.00);Hodges-Lehmann 中位数差值的95%置信区间为(-1.00,0),上限0<1.00,非劣效性成立.入PACU时,对照组和试验组的RSS评分分别为2.00(2.00,3.00)和 3.00(2.50,3.00),RASS 评分分别为 0(-1.00,0)和-1.00(-1.00,-0.50)分,NRS 评分分别为 0(0,1.50)和 0(0,1.00)分,BCS评分分别为 3.00(2.00,4.00)和 3.00(2.00,4.00)分;出 PACU 时,RSS 评分分别为 2.00(2.00,2.00)和 2.00(2.00,2.00)分,RASS 评分分别为 0(0,0)和0(0,0)分,BCS 评分分别为 2.00(2.00,3.50)和 2.00(2.00,4.00)分;术后 24 h,QoR-15 评分分别为 132.00(111.00,141.00)和 133.00(120.00,140.00)分,RCSQ 评分分别为 80.00(61.00,84.00)和 74.00(48.50,82.00)分,在 PACU 补救镇痛率分别为16.28%(7例/43例)和6.98%(3例/43例),除入PACU时的RSS评分和RASS评分在统计学上差异均有统计学意义(均P<0.05),其他上述指标组间比较,在统计学上差异均无统计学意义(均P>0.05).2组均未出现需要临床干预的不良反应.结论 右酮洛芬氨丁三醇注射液50 mg用于妇科短小日间手术术后镇痛,在出PACU时NRS评分方面非劣效于氟比洛芬酯注射液50 mg,2组在舒适度、恢复质量及睡眠评分方面相当,且均具有良好的安全性.右酮洛芬氨丁三醇注射液可作为妇科日间手术多模式镇痛的有效替代药物.

Objective To compare the non-inferiority of dexketoprofen trometamol injection versus flurbiprofen axetil injection for postoperative analgesia in minor gynecological day surgery.Methods This was a single-center,prospective,randomized,double-blind,active-controlled,parallel-group,non-inferiority trial.Patients[American Society of Anesthesiologists(ASA)Ⅰ-Ⅱ]scheduled for elective minor gynecological day surgery were enrolled and randomly assigned into control group and treatment group.Patients in treatment group received intravenous dexketoprofen trometamol injection 50 mg,while those in control group received intravenous flurbiprofen axetil injection 50 mg,both administered 10 minutes before the end of surgery.The numerical rating scale(NRS)pain score at the time of discharge from the post-anesthesia care unit(PACU)with a non-inferiority margin set at 1.0 point,the Ramsay sedation scale(RSS),Richmond agitation-sedation scale(RASS),Bruggrmann comfort scale(BCS),rescue analgesic rate at PACU discharge and admission,as well as the quality of recovery-15(QoR-15)score and Richards-Campbell sleep questionnaire(RCSQ)score at 24 hours postoperatively were compared.Adverse events were also recorded.Results A total of 86 patients were enrolled,with 43 cases in each group.At PACU discharge,the NRS scores of the control group and the treatment group were 1.00(1.00,2.00)and 2.00(0,2.00),respectively;the 95%confidence interval(CI)for the Hodges-Lehmann median difference was(-1.00,0);as the upper bound of the 95%CI(0)fell below the non-inferiority margin of 1.00,non-inferiority was established.At PACU admission,the RSS scores of control and treatment group were 2.00(2.00,3.00)and 3.00(2.50,3.00),respectively;the RASS scores were 0(-1.00,0)and-1.00(-1.00,-0.50)scores,respectively;the NRS scores were 0(0,1.50)and 0(0,1.00)scores,respectively;the BCS scores were 3.00(2.00,4.00)and 3.00(2.00,4.00)scores,respectively;at PACU discharge,the RSS scroes were 2.00(2.00,2.00)and 2.00(2.00,2.00)scores,respectively;the RASS scores were 0(0,0)and 0(0,0)scores,respectively;the BCS scores were 2.00(2.00,3.50)and 2.00(2.00,4.00)scores,respectively;at 24 hours postoperatively,the QoR-15 scores were 132.00(111.00,141.00)and 133.00(120.00,140.00)scores,respectively;the RCSQ scores were 80.00(61.00,84.00)and 74.00(48.50,82.00)scores,respectively;the rescue analgesia rates during PACU stay were 16.28%(7 cases/43 cases)and 6.98%(3 cases/43 cases).Except the RSS scores and RASS scores at PACU admission,which showed statistically significant differences(both P<0.05),the differences of above indicators were all not statistically significant(all P>0.05).No adverse events requiring clinical intervention occurred in either group.Conclusion Dexketoprofen trometamol injection 50 mg is non-inferior to flurbiprofen axetil injection 50 mg for postoperative analgesia in minor gynecological day surgery as measured by NRS score at PACU discharge.The two agents are comparable in terms of comfort,recovery quality,and sleep scores,and both exhibit a favorable safety profile.Dexketoprofen trometamol injection can serve as an effective alternative for multimodal analgesia in gynecological day surgery.

高世龙;杨艳玲;全秀静;王学军;张培福

青海红十字医院麻醉科,青海西宁 810000高原医学研究中心,青海西宁 810000青海红十字医院麻醉科,青海西宁 810000青海红十字医院麻醉科,青海西宁 810000青海红十字医院麻醉科,青海西宁 810000

医药卫生

右酮洛芬氨丁三醇注射液氟比洛芬酯注射液非劣效性试验妇科日间手术术后镇痛

dexketoprofen trometamol injectionflurbiprofen axetil injectionnon-inferiority trialgynecological day surgerypostoperative analgesia

《中国临床药理学杂志》 2026 (16)

2283-2288,6

青海省卫生健康系统指导性计划课题(2025-wjzdx-81)青海省"昆仑英才·高端创新创业人才"(QHK-LYC-GDCXCY-2023-016)

10.13699/j.cnki.1001-6821.2026.16.006

评论